Brook Byers

Brook Byers

Signal active

Co-Founder

Bio

Brook Byers is the Board Director of Foundation Medicine Inc. He has been a venture capital investor since 1972. He has been closely involved with more than fifty new technology based ventures, over half of which have already become public companies.

He formed the first Life Sciences practice group in the venture capital profession in 1984 and led KPCB to become a premier venture capital firm in the medical, healthcare, and biotechnology sectors. KPCB has invested in and helped build over 110 Life Sciences companies which have already developed hundreds of products to treat major underserved medical needs for millions of patients.

Brook was the founding President and then Chairman, of four biotechnology companies which were incubated in KPCB's offices and went on to become public companies with an aggregate market value over $8 Billion.

He is currently on the Board of Directors of nine companies, most recently joining CardioDX, Genomic Health Incorporated, Five Prime Therapeutics, OptiMedica, Pacific Biosciences, Inc., Tethys, XDx, Inc

He was formerly a Director of Idec Pharmaceuticals (Chairman), Athena Neurosciences (Chairman), Signal Pharmaceuticals, Arris Pharmaceuticals, Pharmacopeia, Hybritech (Chairman), Genprobe and others. These companies have pioneered the medical use of molecular biology, monoclonal antibodies, molecular diagnostics and genomics.

Brook was President and a Director of the Western Association of Venture Capitalists. He is a currently a Board member of the University of California at San Francisco Medical Foundation, the New Schools Foundation, Stanford Bio-X Advisory Council and the Stanford Eye Council.

He was Co - Chair of the five year, $1.4 billion, UCSF Capital Campaign. In 2007, he was awarded the UCSF Medal as their honorary degree equivalent.

He was formerly a Director of the Entrepreneurs Foundation, the California Healthcare Institute, the Asian Art Museum in San Francisco, the Stanford Graduate School of Business Advisory Council, That Many May See (UCSF) Vision Research Foundation (Chairman) and the Georgia Tech Advisory Board.

Raised in Atlanta, Georgia, Brook graduated in Electrical Engineering from Georgia Tech. He received an MBA from Stanford.

Location

San Francisco, California, United States, North America

Social

Primary Organization

Kleiner Perkins

Kleiner Perkins

Founded

1972

Investment

1413

Lead investment

403

Exits

337

Employees

251-500

Industry

Financial Services, Venture Capital, Finance, Incubators

Jobs history

4

Board Member

Invalid date - Current

Ligand Pharmaceuticals

Founder

Invalid date - Current

Enjoy

Board Member

Invalid date - Current

Verana Health

Board Member

Invalid date - Current

Board and Advisor Roles

0

N/A

Invest in regions

Profile Resume

Brook Byers is the Co-Founder at Kleiner Perkins, based in United States, North America. With a background in Financial Services, Brook Byers has a rich history of leadership and innovation. Brook Byers studied MBA unknown @ Stanford University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.

Recommendation from your interest

John Doerr

John Doerr

Partner and Chairman

Greg McAdoo

Greg McAdoo

General Partner

Asher Delug

Asher Delug

No designation

Andrew L. Farkas

Andrew L. Farkas

Founder, CEO and Chairman

Drew Houston

Drew Houston

Co-founder & CEO

N/A

Investment portfolio

Brook Byers has made 10 investments. Their Latest investment was Series A - Regard on Jun 29, 2022

Number of investment

10

Number of exits

0

Personal investment

10

Annouced DateOrganization NameFunding RoundMoney Raised
Jan 14, 2022
Verana Health Verana Health
Series E - Verana Health
150.0M
Jan 25, 2022
Leyden Labs Leyden Labs
Series B - Leyden Labs
140.0M
Feb 03, 2022
HealthRhythms HealthRhythms
Seed Round - HealthRhythms
11.0M
Jun 29, 2022
Regard Regard
Series A - Regard
15.3M

Partner investment

5

Annouced DateOrganization NameFunding RoundInvestor NameMoney Raised
Apr 15, 2004
CareDx CareDx
Series C - CareDx
CareDx Kleiner Perkins
14.8M
Apr 26, 2006
OptiMedica OptiMedica
Series B - OptiMedica
OptiMedica Kleiner Perkins
0
Jul 14, 2008
PacBio PacBio
Series E - PacBio
PacBio Kleiner Perkins
100.0M
Oct 23, 2008
CardioDx CardioDx
Series C - CardioDx
CardioDx Kleiner Perkins
20.0M

Exits

0

There is no exit available on this Profile

Invest in industries

Recent Activity

There is no recent news or activity for this profile.